|
MechanismMicrotubule-associated proteins inhibitors |
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1981 |
Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date08 Jun 1964 |
100 Clinical Results associated with Hubei Kelun Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Hubei Kelun Pharmaceutical Co., Ltd.
100 Deals associated with Hubei Kelun Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Hubei Kelun Pharmaceutical Co., Ltd.